Institut Jules Bordet at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Institut Jules Bordet takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on invasive lobular breast cancer and on stage III and early stage non-small cell lung cancer, including when to give immunotherapy after surgery. Other sessions cover tracking genomic evolution and lineage plasticity to guide therapy, and advanced breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Institut Jules Bordet Anderlecht, Belgium | |
Public cancer hospital in Anderlecht, Brussels, Belgium, part of the Université libre de Bruxelles university hospital network. | Chair Fri Oct 23 13:30–14:45 Talk Fri Oct 23 13:30–13:35 Presentation of case/condition Breast cancer Chair Sat Oct 24 10:15–11:30 Borderline resectable, non-oncogene driven stage III NSCLC Lung & thoracic cancers Talk Sat Oct 24 10:15–10:20 Presentation of case/condition Lung & thoracic cancers Chair Sat Oct 24 10:15–11:45 Rapid oral 1: Breast cancer, advanced stage Breast cancer Abstract Sat Oct 24 10:47–10:59 Invited Discussant LBA17 and 3RO Breast cancer Chair Sun Oct 25 10:15–11:00 Tracking genomic evolution and lineage plasticity to guide therapy Biomarkers & precision oncology Talk Mon Oct 26 16:50–17:10 |
Instantly find 20 buyers from Institut Jules Bordet
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction